60 related articles for article (PubMed ID: 591830)
1. (3H)Tamoxifen binding studies in dimethylbenzanthracene-induced mammary carcinomata [proceedings].
Nicholson RI; Daniel CP; Davies P; Griffiths K
J Endocrinol; 1977 Dec; 75(3):26P. PubMed ID: 591830
[No Abstract] [Full Text] [Related]
2. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
[No Abstract] [Full Text] [Related]
3. [Estradiol receptors in the plasma membranes of cells in hormone-dependent mammary tumors].
Morozova TM; Volchkov VE; Merkulova TI; Nagibneva IN
Dokl Akad Nauk SSSR; 1983; 272(6):1494-7. PubMed ID: 6418499
[No Abstract] [Full Text] [Related]
4. Proceedings: Effects of oestradiol-17 beta and ICI 46,474 on total and accessible cytoplasmic oestradiol-17 beta receptors in dimethylbenzanthracene-induced rat mammary tumours.
Nicholson RI; Golder MP; Davies P; Griffiths K
J Endocrinol; 1976 Jun; 69(3):50P-51P. PubMed ID: 181519
[No Abstract] [Full Text] [Related]
5. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
Robinson SP; Jordan VC
Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
[TBL] [Abstract][Full Text] [Related]
6. Fluoresceinated estrone binding by human and mouse breast cancer cells.
Fisher B; Gunduz N; Zheng S; Saffer EA
Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802
[No Abstract] [Full Text] [Related]
7. [Effect of malignant tumors with various characteristics on the state of the estradiol receptor system in peripheral target organs].
Savinskaia AP; Boguslavskaia EV
Biull Eksp Biol Med; 1984 Jan; 97(1):79-81. PubMed ID: 6546352
[TBL] [Abstract][Full Text] [Related]
8. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
9. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
Mehta RG; Cerny WL; Moon RC
Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.
Chander SK; McCague R; Luqmani Y; Newton C; Dowsett M; Jarman M; Coombes RC
Cancer Res; 1991 Nov; 51(21):5851-8. PubMed ID: 1933854
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
Inoh A; Kamiya K; Fujii Y; Yokoro K
Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
Edery M; Drosdowsky MA
Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
[TBL] [Abstract][Full Text] [Related]
13. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M
Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696
[TBL] [Abstract][Full Text] [Related]
16. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
17. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
Nicholson RI; Syne JS; Daniel CP; Griffiths K
Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
[No Abstract] [Full Text] [Related]
18. Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites.
Wakeling AE; Slater SR
Cancer Treat Rep; 1980; 64(6-7):741-4. PubMed ID: 7427959
[TBL] [Abstract][Full Text] [Related]
19. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
Merkulova TI; Morozova TM; Sakganik RI
Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen tolerance and steroid receptors in a tumor model.
Kellen JA; Sutherland DJ
In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
